Quantum Biopharma (QNTM) Current Assets (2018 - 2026)
Quantum Biopharma (QNTM) posted Current Assets of $10.4 million for Q1 2026, up 60.06% sequentially from $6.5 million in Q4 2025, and up 4.4% YoY from $9.9 million in Q1 2025.
Quantum Biopharma (QNTM) Current Assets (2018 - 2026) Analysis & Trends
Quantum Biopharma has reported Current Assets for 9 years, with the latest figure at $10.4 million in Q1 2026.
- Quarterly Current Assets rose 4.4% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (up 4.4% YoY) and the FY2025 annual result came in at $6.5 million, down 46.25% from the prior year.
- Current Assets climbed to $10.4 million in Q1 2026 per QNTM's latest filing, from $6.5 million in the prior quarter.
- Over five years, Current Assets peaked at $17.9 million in Q4 2022 and troughed at $6.5 million in Q4 2025.
- A 5-year average of $11.1 million and a median of $10.4 million in 2025 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2024: Current Assets tumbled 61.14% in 2022, then gained 8.73% in 2024.
- Over 5 years, Current Assets stood at $17.9 million in 2022, then plunged by 37.9% to $11.1 million in 2023, then climbed by 8.73% to $12.1 million in 2024, then tumbled by 46.25% to $6.5 million in 2025, then surged by 60.06% to $10.4 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $10.4 million, $6.5 million, and $9.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 1.76 Bn |
| 10 | Quantum Biopharma | 15.40 Mn | 11.75 Mn | - | 9.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.96 Mn |
| Mar 31, 2026 | 10.37 Mn |
| Dec 31, 2025 | 6.48 Mn |
| Sep 30, 2025 | 9.34 Mn |
| Jun 30, 2025 | 10.34 Mn |
| Mar 31, 2025 | 9.93 Mn |
| Dec 31, 2024 | 12.05 Mn |
| Sep 30, 2024 | 13.84 Mn |
| Jun 30, 2024 | 10.02 Mn |
| Dec 31, 2023 | 11.09 Mn |
| Dec 31, 2022 | 17.85 Mn |
| Dec 31, 2021 | 45.93 Mn |
| Dec 31, 2020 | 26.87 Mn |
| Dec 31, 2019 | 8.62 Mn |
| Dec 31, 2018 | 17.10 Mn |